Life Pharma To Build $160 Million Worth Of Plants In Abu Dhabi
This article was originally published in PharmAsia News
Life Pharma, a unit of VPS Healthcare in Abu Dhabi, said it would spend $160 million to build production facilities in a local industrial zone to make generic versions of cancer and other drugs.
You may also be interested in...
A report from the US FDA says the agency will focus on updating its premarket submission portal, training staff and taking additional steps to start taking in applications for ASCA pilot participant sponsors.
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.